Tripura CM urges Centre to increase upper loan cap in externally aided projects
According to existing guidelines, the northeastern state can take a maximum loan amounting to ₹4,000 crore under externally aided projects in a financial year.
While speaking at a government programme in Kashba in Sepahijala district, the chief minister said that with the state spending a huge amount of money on infrastructure building, the upper limit of loans under externally aided schemes often falls short for undertaking new projects.
"At present, we are allowed to receive loans amounting to ₹4,000 crore under externally aided projects in a financial year, which is not sufficient for the state. I have already written to the Centre to increase the upper cap of receiving loans to speed up development," he said.
Asserting that tourism can boost the state's socio-economic condition, the chief minister said the government has increased the annual budget substantially to develop infrastructure as much as possible.
"The state's budget has increased from ₹27,000 crore in 2024-25 FY to ₹32,000 crore during the fiscal 2025-26, and ₹7,000 crore has been earmarked for capital expenditure. If we spend more on infrastructure, the GSDP will increase," he said.
"Despite being a small state, Sikkim, with a population of 7 lakh, has the highest gross state domestic product among the eight northeastern states, banking on tourism. If we develop tourism-related infrastructures, Tripura can surpass Sikkim," he said.
Currently, Tripura has the second-highest GSDP.Saha said the Tourism department has taken several initiatives to promote the state's spiritual and eco tourism globally.
"Tata Group is set to convert the iconic Ujjayanta Palace in Agartala into a five-star hotel. Once the project is completed, tourists from foreign nations will visit the northeastern state to see temples, iconic structures and eco tourism sites," he said.
Taking a dig at the erstwhile government, the chief minister said the previous dispensation did not try to develop the royal family's historic buildings.
"We have begun to restore and develop the royal structures, including the Ujjayanta Palace, to present their creations before the world," he said.
This article was generated from an automated news agency feed without modifications to text.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scroll.in
2 hours ago
- Scroll.in
Bengal governor returns bill proposing death penalty for rape convicts to state for reconsideration
West Bengal Governor CV Ananda Bose has returned the 2024 Aparajita Bill to the state government to consider the objections raised by the Centre about the death penalty provisions in the draft legislations, The Hindu reported on Friday. One of the proposed amendments seeks to increase the punishment for rape under Section 64 of the Bharatiya Nyaya Sanhita from the current minimum 10-year imprisonment to life imprisonment or death penalty. The Ministry of Home Affairs has said that the change is ' excessively harsh and disproportionate', The Indian Express quoted an unidentified Raj Bhawan official as saying. Additionally, the bill proposes making the death penalty mandatory in cases involving the victim's death or persistent vegetative state under Section 66 of the BNS. 'The ministry has raised concerns over the removal of judicial discretion in such cases,' The Indian Express quoted the official as saying. The state government has not commented on the matter so far. The West Bengal Assembly had unanimously passed the Aparajita Women and Child West Bengal Criminal Laws Amendment Bill in September 2024. The state government had said that the legislation was aimed at creating a ' safer environment for women and children ' by ensuring more stringent punishments for rape and related crimes. The bill sought to amend sections of the Bharatiya Nyaya Sanhita pertaining to punishments for acid attacks, rape, rape and murder, gangrape, repeat sex offenders and the disclosure of a rape victim's identity. It also seeks to do away with the concessions granted to juvenile sex offenders under the law. It proposes the death penalty for rape convicts.
Hans India
3 hours ago
- Hans India
Farmers get Rs 49,330-cr fertiliser subsidy till July 21
New Delhi: The Centre has provided fertilisers subsidy of Rs49,330 crore till July 21 of this fiscal to ensure farmers get key nutrients at a reasonable a written reply to Lok Sabha on Friday, Minister of State of Chemicals and FertilisersAnupriya Patel informed that the total fertilizer subsidy provided by the government stood at Rs49,329.88 crore till July 21 of 2025-26 fiscal. Out of this, Rs30,940.82 crore subsidy was towards domestic urea, while Rs4,006.70 crore for imported urea. In 2022-23, the Centre's fertiliser subsidy stood at Rs2,54,798.88 crore. The subsidy declined to Rs1,95,420.51 crore in 2023-24 and Rs1,77,129.50 crore in 2024-25. 'Under 'DBT in Fertilizers' system, 100 per cent subsidy on various fertilizer grades is released to the fertilizer companies, on actual sales to the beneficiaries based on Aadhar authentication through POS devices installed at each retail shop,' Patel said. All farmers (including small, medium and large farmers) are being supplied fertilisers at subsidized rates, she added.
India.com
3 hours ago
- India.com
India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister
New Delhi: Various schemes being implemented by the Centre to realise the vision of Aatmanirbhar Bharat in the pharmaceutical sector have resulted in India's exports of drugs and pharmaceuticals increasing by 92 per cent, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, the Parliament was informed on Friday. The schemes include the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, the PLI Scheme for Bulk Drugs, Scheme for Promotion of Bulk Drug Parks, and Strengthening of Pharmaceutical Industry scheme, Minister of State for Chemicals and Fertilisers Anupriya Patel told the Lok Sabha in a written reply to a question. The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India's Pharma MedTech sector from cost- to innovation-based growth by strengthening research and promoting industry-academia linkage for research and development in priority areas in drug discovery and development and medical devices. Under this scheme, seven Centres of Excellence (CoEs) have been set up, she said. The PLI Scheme for Pharmaceuticals aims to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high-value goods in the pharmaceutical sector. The minister said that the scheme has enabled enhanced investment and production in eligible products. As of March 2025, the committed investment of Rs 17,275 crore targeted over the six-year period of the scheme stands substantially exceeded with a cumulative investment of Rs 37,306 crore made by the scheme's third year, and cumulative sales of approved products of Rs 2,66,528 crore have been made, including exports of Rs 1,70,807 crore. The PLI Scheme for Bulk Drugs, which has a total budgetary outlay of Rs 6,940 crore, aims to avoid disruption in the supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs for which there are no alternatives by reducing supply disruption risk due to excessive dependence on a single source. As of March 2025, the committed investment of Rs 3,938.5 crore under projects approved under the scheme for investment over the six-year production period of the scheme stands substantially exceeded with a cumulative investment of Rs 4,570 crore made by the scheme's third year, she further stated. The minister also highlighted that the government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to make quality generic medicines available at affordable prices to all. Under the scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to provide medicines at prices that are about 50 per cent to 80 per cent lower than those of leading branded medicines in the market. Till June 6, 2025, a total of 16,912 JAKs have been opened, and on average, about 10 to 12 lakh persons visit these Kendras daily and avail of quality medicines at affordable prices. As many as 2,110 medicines and 315 surgicals, medical consumables and devices are under the scheme product basket, covering all major therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-allergic and gastro-intestinal medicines and nutraceuticals. As a result of the scheme, in the last 11 years, estimated savings of about Rs 38,000 crore have accrued to citizens in comparison to the prices of branded medicines. Further, the scheme has provided self-employment to over 16,000 persons, including over 6,800 women entrepreneurs, the minister added.
